...
首页> 外文期刊>Medical Physics >Point/counterpoint. Molecular breast imaging will soon replace x-ray mammography as the imaging modality of choice for women at high risk with dense breasts.
【24h】

Point/counterpoint. Molecular breast imaging will soon replace x-ray mammography as the imaging modality of choice for women at high risk with dense breasts.

机译:点/对点。乳腺分子成像将很快取代X线乳房X线照相术,成为高风险,乳房密实妇女的首选成像方式。

获取原文
获取原文并翻译 | 示例
           

摘要

X-ray mammography has been the mainstay of breast cancer screening for decades, with excellent results. There is a problem, however, with detection of cancers in women at high risk and/or with dense breasts. For this population of patients, other modalities are being studied and some, such as molecular breast imaging (MBI), have shown sufficient promise to encourage some to suggest that MBI will soon replace x-ray mammography as the imaging modality of choice for women at high risk with dense breasts. This is the proposition debated in this month's Point/Counterpoint.
机译:数十年来,X射线乳房摄影术一直是乳腺癌筛查的主要手段,并取得了优异的成绩。然而,在高风险妇女中和/或乳房密实的妇女中检测癌症存在问题。对于这种患者群体,正在研究其他方式,例如分子乳腺成像(MBI)已显示出足够的前景,可以鼓励一些人建议MBI将很快取代X线乳房X线照相术作为女性选择的成像方式。乳房密集的高风险。这是本月要点/对等点中讨论的命题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号